• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

速释口服剂型开发中的体内-体外相关性考量

IV-IVC considerations in the development of immediate-release oral dosage form.

作者信息

Li Shoufeng, He Handan, Parthiban Lakshman J, Yin Hequn, Serajuddin Abu T M

机构信息

Pharmaceutical Development Section, Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ 07936, USA.

出版信息

J Pharm Sci. 2005 Jul;94(7):1396-417. doi: 10.1002/jps.20378.

DOI:10.1002/jps.20378
PMID:15920764
Abstract

Predictive scientific principles and methods to assess in vivo performance of pharmaceutical dosage forms based on in vitro studies are important in order to minimize costly animal and human experiments during drug development. Because of issues related to poor solubility and low permeability of newer drug candidates, there has in recent years been a special focus on in vitro-in vivo correlation (IV-IVC) of drug products, particularly those used orally. Various physicochemical, biopharmaceutical, and physiological factors that need to be considered in successful IV-IVC of immediate-release oral dosage forms are reviewed in this article. The physicochemical factors include drug solubility in water and physiologically relevant aqueous media, pK(a) and drug ionization characteristics, salt formation, drug diffusion-layer pH, particle size, polymorphism of drug substance, and so forth. The biopharmaceutical factors that need to be considered include effects of drug ionization, partition coefficient, polar surface area, etc., on drug permeability, and some of the physiological factors are gastrointestinal (GI) content, GI pH, GI transit time, etc. Various in silico, in vitro, and in vivo methods of estimating drug permeability and absorption are discussed. Additionally, how IV-IVC may be applied to immediate-release oral dosage form design are presented.

摘要

基于体外研究评估药物剂型体内性能的预测性科学原理和方法对于在药物开发过程中尽量减少昂贵的动物和人体实验非常重要。由于新型候选药物存在溶解度差和渗透性低等问题,近年来特别关注药物产品的体外-体内相关性(IV-IVC),尤其是口服制剂。本文综述了速释口服剂型成功实现IV-IVC时需要考虑的各种物理化学、生物药剂学和生理学因素。物理化学因素包括药物在水和生理相关水性介质中的溶解度、pK(a)和药物电离特性、盐的形成、药物扩散层pH值、粒径、药物多晶型等。需要考虑的生物药剂学因素包括药物电离、分配系数、极性表面积等对药物渗透性的影响,一些生理学因素包括胃肠道(GI)内容物、GI pH值、GI转运时间等。讨论了各种预测药物渗透性和吸收的计算机模拟、体外和体内方法。此外,还介绍了IV-IVC如何应用于速释口服剂型设计。

相似文献

1
IV-IVC considerations in the development of immediate-release oral dosage form.速释口服剂型开发中的体内-体外相关性考量
J Pharm Sci. 2005 Jul;94(7):1396-417. doi: 10.1002/jps.20378.
2
In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.在药物产品开发中的胃肠道药物吸收的计算预测:机制吸收模型 GI-Sim 的应用。
Eur J Pharm Sci. 2013 Jul 16;49(4):679-98. doi: 10.1016/j.ejps.2013.05.019. Epub 2013 May 29.
3
PBPK models for the prediction of in vivo performance of oral dosage forms.用于预测口服剂型体内性能的生理药代动力学(PBPK)模型。
Eur J Pharm Sci. 2014 Jun 16;57:300-21. doi: 10.1016/j.ejps.2013.09.008. Epub 2013 Sep 21.
4
Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo.口服生物药剂学工具——开启新计划的时机——IMI项目OrBiTo介绍
Eur J Pharm Sci. 2014 Jun 16;57:292-9. doi: 10.1016/j.ejps.2013.10.012. Epub 2013 Nov 1.
5
Application of in vitro biopharmaceutical methods in development of immediate release oral dosage forms intended for paediatric patients.在儿童患者用即释口服剂型开发中应用体外生物药剂学方法。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):833-42. doi: 10.1016/j.ejpb.2013.04.015. Epub 2013 May 9.
6
In vitro models for the prediction of in vivo performance of oral dosage forms.用于预测口服剂型体内性能的体外模型。
Eur J Pharm Sci. 2014 Jun 16;57:342-66. doi: 10.1016/j.ejps.2013.08.024. Epub 2013 Aug 27.
7
Human in vivo regional intestinal permeability: importance for pharmaceutical drug development.人体内肠道局部通透性:对药物研发的重要性。
Mol Pharm. 2014 Jan 6;11(1):12-23. doi: 10.1021/mp4003392. Epub 2013 Nov 22.
8
A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.一种使用GastroPlus作为药代动力学模拟工具的临床前制剂开发策略以及应用于犬类研究的统计筛选设计。
Eur J Pharm Sci. 2006 Jan;27(1):91-9. doi: 10.1016/j.ejps.2005.08.011. Epub 2005 Oct 10.
9
In vitro-in vivo-in silico approach in biopharmaceutical characterization of ibuprofen IR and SR tablets.布洛芬速释片和缓释片生物制药特性的体外-体内-计算机模拟方法
Eur J Pharm Sci. 2015 Jul 30;75:151-9. doi: 10.1016/j.ejps.2015.03.027. Epub 2015 Apr 7.
10
In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.体外溶出方法,微型胃肠道模拟器(mGIS),能更好地预测弱碱性药物达沙替尼的体内溶出情况。
Eur J Pharm Sci. 2015 Aug 30;76:203-12. doi: 10.1016/j.ejps.2015.05.013. Epub 2015 May 12.

引用本文的文献

1
Novel First-Generation Dissolution Models to Investigate the Release and Uptake of Oral Lymphotropic Drug Products.新型第一代溶出模型研究口服淋巴靶向药物制剂的释放和摄取。
AAPS PharmSciTech. 2024 Aug 14;25(6):187. doi: 10.1208/s12249-024-02866-y.
2
Thermal degradation of Affinisol HPMC: Optimum Processing Temperatures for Hot Melt Extrusion and 3D Printing.阿菲尼索尔 HPMC 的热降解:热熔挤出和 3D 打印的最佳加工温度。
Pharm Res. 2023 Sep;40(9):2253-2268. doi: 10.1007/s11095-023-03592-z. Epub 2023 Aug 23.
3
Discovery of Novel HIV Protease Inhibitors Using Modern Computational Techniques.
利用现代计算技术发现新型 HIV 蛋白酶抑制剂。
Int J Mol Sci. 2022 Oct 12;23(20):12149. doi: 10.3390/ijms232012149.
4
Lipid-based emulsion drug delivery systems - a comprehensive review.基于脂质的乳液药物递送系统——综述
Drug Deliv Transl Res. 2022 Jul;12(7):1616-1639. doi: 10.1007/s13346-021-01071-9. Epub 2021 Oct 5.
5
Predicting Pharmacokinetic Properties of Potential Anticancer Agents via Their Chromatographic Behavior on Different Reversed Phase Materials.通过不同反相材料上的色谱行为预测潜在抗癌剂的药代动力学性质。
Int J Mol Sci. 2021 Apr 20;22(8):4257. doi: 10.3390/ijms22084257.
6
Estimating the Oral Absorption from Self-Nanoemulsifying Drug Delivery Systems Using an In Vitro Lipolysis-Permeation Method.使用体外脂解-渗透法评估自纳米乳化药物递送系统的口服吸收情况。
Pharmaceutics. 2021 Apr 2;13(4):489. doi: 10.3390/pharmaceutics13040489.
7
Development of a Clinically Relevant Dissolution Method for Metaxalone Immediate Release Formulations Based on an IVIVC Model.基于 IVIVC 模型的美索巴莫速释制剂临床相关溶出方法的开发。
Pharm Res. 2018 Jun 22;35(8):163. doi: 10.1007/s11095-018-2434-1.
8
Development of Fast-Dissolving Amorphous Solid Dispersion of Itraconazole by Melt Extrusion of its Mixture with Weak Organic Carboxylic Acid and Polymer.采用熔融挤出技术制备伊曲康唑无定形固体分散体的研究
Pharm Res. 2018 Apr 25;35(7):127. doi: 10.1007/s11095-018-2407-4.
9
Investigation of Thermal and Viscoelastic Properties of Polymers Relevant to Hot Melt Extrusion, IV: Affinisol™ HPMC HME Polymers.与热熔挤出相关的聚合物的热性能和粘弹性研究,IV:Affinisol™ HPMC HME聚合物
AAPS PharmSciTech. 2016 Feb;17(1):148-57. doi: 10.1208/s12249-015-0426-6. Epub 2015 Oct 28.
10
Exploring the chemical space of aromatase inhibitors.探索芳香化酶抑制剂的化学空间。
Mol Divers. 2013 Nov;17(4):661-77. doi: 10.1007/s11030-013-9462-x. Epub 2013 Jul 16.